España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Lisata Therapeutics
LSTA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Lisata Therapeutics (LSTA) Forecast
News
Earnings
Lisata Therapeutics (LSTA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Lisata Therapeutics (NASDAQ:LSTA) Stock
Lisata Therapeutics Stock (NASDAQ: LSTA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 11, 2024
HC Wainwright & Co. Reiterates Buy on Lisata ...
Benzinga Newsdesk
Tuesday, December 10, 2024
Lisata Therapeutics Announces Completion Of E...
Benzinga Newsdesk
Tuesday, December 03, 2024
Lisata Therapeutics And Kuva Labs Announce A ...
Benzinga Newsdesk
Thursday, November 21, 2024
HC Wainwright & Co. Reiterates Buy on Lisata ...
Benzinga Newsdesk
Tuesday, November 12, 2024
Lisata Therapeutics Q3 EPS $(0.59) Beats $(0....
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
Earnings Outlook For Lisata Therapeutics
Benzinga Insights
Wednesday, November 06, 2024
Lisata Therapeutics And Valo Therapeutics Ann...
Benzinga Newsdesk
Monday, October 28, 2024
Lisata Therapeutics Entered Into Sponsored Pr...
Benzinga Newsdesk
Wednesday, September 18, 2024
HC Wainwright & Co. Reiterates Buy on Lisata ...
Benzinga Newsdesk
Tuesday, September 17, 2024
Lisata Therapeutics shares are trading higher...
Benzinga Newsdesk
Lisata Therapeutics Announces First Patient T...
Benzinga Newsdesk
Thursday, September 05, 2024
Lisata Therapeutics' Certepetide Granted FDA ...
Benzinga Newsdesk
Tuesday, August 13, 2024
HC Wainwright & Co. Reiterates Buy on Lisata ...
Benzinga Newsdesk
Monday, August 12, 2024
Lisata Therapeutics Q2 2024 GAAP EPS $(0.61) ...
Benzinga Newsdesk
Wednesday, July 24, 2024
Quest Diagnostics' Haystack Oncology Forges New MRD Deal
Zacks
Friday, July 19, 2024
HC Wainwright & Co. Reiterates Buy on Lisata ...
Benzinga Newsdesk
Thursday, July 18, 2024
EXCLUSIVE: Lisata Therapeutics Tells Benzinga...
Benzinga Newsdesk
EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy
Vandana Singh
Tuesday, July 16, 2024
Lisata Stock Rallies More Than 30% YTD: Here's Why
Zacks
Lisata Therapeutics Completes Enrollment In I...
Benzinga Newsdesk
Wednesday, July 10, 2024
HC Wainwright & Co. Reiterates Buy on Lisata ...
Benzinga Newsdesk
Lisata Therapeutics Reports Preclinical Resul...
Benzinga Newsdesk
Friday, June 14, 2024
HC Wainwright & Co. Reiterates Buy on Lisata ...
Benzinga Newsdesk
Thursday, June 13, 2024
Lisata Therapeutics Completes Full Enrollment...
Benzinga Newsdesk
Tuesday, May 21, 2024
HC Wainwright & Co. Reiterates Buy on Lisata ...
Benzinga Newsdesk
Monday, May 20, 2024
Lisata Therapeutics Reaches Agreement With EM...
Benzinga Newsdesk
Thursday, May 09, 2024
Lisata Therapeutics Q1 2024 GAAP EPS $(0.65) ...
Benzinga Newsdesk
Friday, April 26, 2024
HC Wainwright & Co. Reiterates Buy on Lisata ...
Benzinga Newsdesk
Thursday, April 25, 2024
HC Wainwright & Co. Reiterates Buy on Lisata ...
Benzinga Newsdesk
Tuesday, April 23, 2024
Lisata Therapeutics And Qilu Pharmaceutical A...
Benzinga Newsdesk
Tuesday, April 09, 2024
Lisata Therapeutics Receives U.S. FDA Orphan ...
Benzinga Newsdesk
Thursday, March 21, 2024
Lisata Therapeutics Announces US FDA Rare Ped...
Benzinga Newsdesk
Friday, March 01, 2024
HC Wainwright & Co. Reiterates Buy on Lisata ...
Benzinga Newsdesk
Thursday, February 29, 2024
Recap: Lisata Therapeutics Q4 Earnings
Benzinga Insights
Lisata Therapeutics Q4 2023 GAAP EPS $(0.660)...
Benzinga Newsdesk
Earnings Scheduled For February 29, 2024
Benzinga Insights
Wednesday, February 28, 2024
Lisata Therapeutics's Earnings Outlook
Benzinga Insights
Wednesday, January 17, 2024
Lisata Therapeutics Announces First Patient T...
Benzinga Newsdesk
Thursday, January 04, 2024
HC Wainwright & Co. Reiterates Buy on Lisata ...
Benzinga Newsdesk
Lisata Therapeutics Announced Publication Of ...
Benzinga Newsdesk
Tuesday, December 12, 2023
Lisata Therapeutics Announces Completion Of E...
Benzinga Newsdesk
Thursday, November 02, 2023
Lisata Therapeutics Q3 EPS $(0.65) Beats $(0....
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Wednesday, November 01, 2023
Earnings Preview: Lisata Therapeutics
Benzinga Insights
Tuesday, October 24, 2023
Lisata Therapeutics Announces First Patient T...
Benzinga Newsdesk
Tuesday, October 17, 2023
Lisata Therapeutics Announces European Medici...
Benzinga Newsdesk
Tuesday, September 12, 2023
Lisata Therapeutics Announced The Treatment O...
Benzinga Newsdesk
Wednesday, September 06, 2023
Lisata Therapeutics Announces Outcome Of Inte...
Benzinga Newsdesk
Tuesday, September 05, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
